BRCA1 gene mutation may raise risk of aggressive endometrial cancer
A new study identifies a greater risk of serous or serous-like endometrial cancer for women with a BRCA1 gene mutation, even after risk-reducing surgery. …read more
A new study identifies a greater risk of serous or serous-like endometrial cancer for women with a BRCA1 gene mutation, even after risk-reducing surgery. …read more
A new study identifies a greater risk of serous or serous-like endometrial cancer for women with a BRCA1 gene mutation, even after risk-reducing surgery. …read more
One in eight women and one in ten men have experienced infertility, yet nearly half of them have not sought medical help, according to a study of more than 15,000 women and men in Britain published… …read more
One in eight women and one in ten men have experienced infertility, yet nearly half of them have not sought medical help, according to a study of more than 15,000 women and men in Britain published… …read more
The largest series of suspected congenital Zika virus cases reported to date showed that microcephaly is not a reliable indication of infection, and normal head circumference does not rule it out. Medscape Medical News …read more
The largest series of suspected congenital Zika virus cases reported to date showed that microcephaly is not a reliable indication of infection, and normal head circumference does not rule it out. Medscape Medical News …read more
Study focuses on proteins, the key molecular players in cancer biology.In what is believed to be the largest study of its kind, scientists at the Pacific Northwest National Laboratory, Johns… …read more
Study focuses on proteins, the key molecular players in cancer biology.In what is believed to be the largest study of its kind, scientists at the Pacific Northwest National Laboratory, Johns… …read more
Dr Peter Kovacs discusses a study examining risk for ovarian hyperstimulation syndrome with GnRH agonist vs GnRH antagonist therapy in patients receiving IVF. Medscape Ob/Gyn …read more
When considering preemptive surgery to prevent ovarian cancer, halving the current risk threshold of 10% is very cost-effective and can extend life expectancy. Medscape Medical News …read more